Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer

Cisplatin resistance remains one of the major obstacles when treating epithelial ovarian cancer. Because oxaliplatin and nedaplatin are effective against cisplatin-resistant ovarian cancer in clinical trials and signal transducer and activator of transcription 3 (STAT3) is associated with cisplatin...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheng, W.J., Jiang, H., Wu, D.L., Zheng, J.H.
Format: Artigo
Language:Inglês
Published: Associação Brasileira de Divulgação Científica 2013
Subjects:
Biomedical Sciences
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854422/
https://ncbi.nlm.nih.gov/pubmed/23969971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20133003
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items